Dendrimeric antigens for passive mast cell activation in the evaluation of amoxicillin allergy
| dc.centro | Facultad de Ciencias | |
| dc.contributor.author | Tesfaye Ayane, Amene | |
| dc.contributor.author | Salas, María | |
| dc.contributor.author | Benede, Sara | |
| dc.contributor.author | Rodríguez-Sánchez, Maria J. | |
| dc.contributor.author | Rodríguez-Sojo, María J. | |
| dc.contributor.author | Jiménez-Sánchez, Isabel M. | |
| dc.contributor.author | Bogas, Gador | |
| dc.contributor.author | Pérez-de-Inestrosa-Villatoro, Ezequiel | |
| dc.contributor.author | Mayorga, Cristobalina | |
| dc.contributor.author | Paris, Juan L. | |
| dc.contributor.author | Rodríguez-Nogales, Alba | |
| dc.contributor.author | Torres-Jaén, María Josefa | |
| dc.contributor.author | Montañez-Vega, María Isabel | |
| dc.date.accessioned | 2026-02-12T12:23:12Z | |
| dc.date.issued | 2026 | |
| dc.departamento | Química Orgánica | |
| dc.description.abstract | Background: Amoxicillin (AX) is frequently implicated in immediate IgE-mediated allergic reactions. Diagnosis is challenging,highlighting the need for new approaches enhancing in vitro sensitivity and specificity. Engineered nanostructures can mimicimmunological recognition of hapten-carrier conjugates, offering a strategy to improve diagnostic accuracy.Methods: Dendrimeric Antigens (DeAns), with controlled size (1st–5th generation) and multivalent AX determinants (8–128 units, respectively), were synthesized for in vitro immunological evaluation. In vitro IgE recognition was studied by com-petitive radio-immunoassay. Allergenic activity was evaluated in mouse bone marrow-derived mast cells (MC) sensitized withmouse anti-AX IgE monoclonal antibody and humanized RBL-2H3 (huRBL-2H3) and LUVA cells sensitized with sera fromβ-lactam-allergic subjects and tolerant controls, measuring degranulation in response to DeAns stimulation.Results: Five different DeAns were obtained as pure compounds. All DeAns were recognized by AX-sIgE. A clear size-dependent activation pattern was observed in the three cell models: lower-generation (1st–2nd) DeAns failed to induce degranu-lation, whereas DeAns of bigger size (3rd–5th generation) triggered significant, dose-dependent activation. Notably, no activationwas observed in tolerants and unsensitized cells or with blank dendrimers. In patient-sera assays, the passive MC activation test(pMAT) with DeAns provided complete diagnostic discrimination, with activation restricted to AX-allergic patients.Conclusions: DeAns are effective platforms for investigating effector cell activation in AX allergy. By fine-tuning structuralattributes—size and multivalence—we reveal the promising utility of DeAns in pMAT that leverage commercial cell lines andpatient sera. This approach could address key limitations of β-lactam allergy diagnostics, enabling more reliable and standard-ized in vitro testing. | |
| dc.description.sponsorship | Funding for open access charge: Universidad de Málaga / CBUA | |
| dc.identifier.citation | A. T. Ayane, M. Salas, S. Benede, et al., “ Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy,” Allergy (2026): 1–12, https://doi.org/10.1111/all.70250. | |
| dc.identifier.doi | https://doi.org/10.1111/all.70250 | |
| dc.identifier.uri | https://hdl.handle.net/10630/45417 | |
| dc.language.iso | eng | |
| dc.publisher | Wiley | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/713721/EU | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/AC19%2F00082/ES/NANODIAGNOSTICO PARA LA HIPERSENSIBILIDAD A BETALACTAMICOS/ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII)/PI17%2F01237/ES/APLICACION DE NANOARQUITECTURAS SINTETICAS AL ESTUDIO DE LOS MECANISMOS DE ACTIVACION DEL BASOFILO Y AL DIAGNOSTICO EN REACCIONES ALERGICAS A AMOXICILINA./ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F00329/ES/OPTIMIZACION DIAGNOSTICA EN ALERGIA A BETALACTAMICOS: DE LA ESTANDARIZACIÓN Y RACIONALIZACIÓN DE LAS PRUEBAS IN VIVO, AL DESARROLLO DE TEST IN VITRO INNOVADORES BASADOS EN NANOTECNOLOGIA Y METABOLÓMICA./ | |
| dc.relation.projectID | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI20%2F01734/ES/NANOARQUITECTURAS ALTAMENTE EFICIENTES PARA UN ENTRECRUZAMIENTO EFICAZ DE LA IGE EN MASTOCITOS Y BASOFILOS. APLICACION AL DIAGNOSTICO DE REACCIONES ALERGICAS A AMOXICILINA Y ACIDO CLAVULANICO./ | |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Antibióticos | |
| dc.subject | Alergia a los medicamentos | |
| dc.subject | Antibióticos betalactámicos | |
| dc.subject | Amoxicilina | |
| dc.subject.other | Aallergy | |
| dc.subject.other | Amoxicillin | |
| dc.subject.other | Dendrimeric antigen | |
| dc.subject.other | Nanostructure | |
| dc.subject.other | Passive mast cell activation test | |
| dc.title | Dendrimeric antigens for passive mast cell activation in the evaluation of amoxicillin allergy | |
| dc.type | journal article | |
| dc.type.hasVersion | AM | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 98747537-47b0-44b3-8957-b82ffe8b4cf3 | |
| relation.isAuthorOfPublication | abcd4607-b47d-4018-86ad-3b5f76cbee1e | |
| relation.isAuthorOfPublication | 2dd035c6-77e1-43d2-b0d8-9054c037065f | |
| relation.isAuthorOfPublication.latestForDiscovery | 98747537-47b0-44b3-8957-b82ffe8b4cf3 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Allergy - 2026 - Ayane - Dendrimeric Antigens for Passive Mast Cell Activation in the Evaluation of Amoxicillin Allergy.pdf
- Size:
- 3.88 MB
- Format:
- Adobe Portable Document Format

